We report a case of congenital orbital teratoma. A 3-day-old male, born at 39 weeks' gestation without relevant prenatal history, presented with a large vascularized proptotic mass distorting the left midface. Laboratory studies showed elevated serum alpha-fetoprotein (12,910 ng/ml). Computed tomography showed a multiloculated heterogeneous lesion composed of hypodense and hyperdense calcified areas encompassing the whole orbital cavity with expansion of the bony walls, as well as forward displacement and compression of the eyeball without extension to surrounding structures. Clinical, imaging and laboratory features were consistent with congenital orbital teratoma. Due to pronounced proptosis with exposure keratopathy and corneal perforation, no motility of the globe and no vision in the affected eye in a resource-limited setting, the patient underwent orbital exenteration. Histopathological examination confirmed the diagnosis of mature cystic teratoma. We describe the clinical course, radiographic and histopathological findings of this rare orbital tumor.

1.
Tapper D, Lack EE: Teratomas in infancy and childhood. A 54-year experience at the Children's Hospital Medical Center. Ann Surg 1983;198:398-410.
2.
Günalp I, Gündüz K: Cystic lesions of the orbit. Int Ophthalmol 1996;20:273-277.
3.
Choi SH, Han YB, Lee TJ: A case of congenital orbital teratoma. Korean J Ophthalmol 1987;1:139-144.
4.
Grube-Pagola P, Hobart-Hernández RI, Martínez-Hernández MA, Gómez-Dorantes SM, Alderete-Vázquez G: Congenital proptosis secondary to orbital teratoma. Clinicopathological study. Arch Soc Esp Oftalmol 2013;88:153-156.
5.
Gnanaraj L, Skibell BC, Coret-Simon J, Halliday W, Forrest C, DeAngelis DD: Massive congenital orbital teratoma. Ophthal Plast Reconstr Surg 2005;21:445-447.
6.
Herman TE, Vachharajani A, Siegel MJ: Massive congenital orbital teratoma. J Perinatol 2009;29:396-397.
7.
Sharma MC, Sarkar C, Gaikwad S, Mahapatra AK, Bahadur S: Congenital orbital teratoma: a report of two cases. Indian J Ophthalmol 1997;45:49-52.
8.
Damato PJ, Damato FJ: Neonatal orbital teratoma. Br J Ophthalmol 1962;46:685-691.
9.
Spinelli HM, Criscuolo GR, Tripps M, Buckley PJ: Massive orbital teratoma in the newborn. Ann Plast Surg 1993;31:453-458.
10.
Patel B: Benign orbital tumors: teratoma; in Perry J, Singh A (eds): Clinical Ophthalmic Oncology: Orbital Tumors, vol 1. Berlin/Heidelberg/New York/Dordrecht/London, Springer, 2014, pp 83-84.
11.
Sreenan C, Johnson R, Russel L, Bhargava R, Osiovich H: Congenital orbital teratoma. Am J Perinatol 1999;16:251-255.
12.
González C, Restrepo C, Salazar G, Monsalve P: Congenital orbital teratoma: case report. Colomb Med (Cali) 2012;43:82-85.
13.
Hann L, Borden S, Weber A: Orbital teratoma in the newborn. A case report. Pediatr Radiol 1977;5:172-174.
14.
Singh U, Subramanian A, Bal A: Congenital orbital teratoma presenting as microphthalmos with cyst. Indian J Ophthalmol 2009;57:474-475.
15.
Fabian ID, Priel A, Fridman E, Rosen N, Barshak I, Greenberg G, Rosner M: Congenital orbital teratoma. Harefuah 2013;152:323-325, 369.
16.
Mee JJ, McKelvie PA, McNab AA: Orbital teratoma: late presentation with normal vision. Clin Experiment Ophthalmol 2002;30:41-43.
17.
Shields JA, Shields CL: Orbital cysts of childhood - classification, clinical features, and management. Surv Ophthalmol 2004;49:281-299.
18.
Ogun OA, Ogun GO, Brown BJ, Mosuro AL, Ashaye AO: Congenital orbital teratoma: a case report and challenges of its management in a resource limited setting. Pan Afr Med J 2012;12:3.
19.
Tsuchida Y, Hasegawa H: The diagnostic value of alpha-fetoprotein in infants and children with teratomas: a questionnaire survey in Japan. J Pediatr Surg 1983;18:152-155.
20.
Heerema-McKenney A, Bowen J, Hill A, Suster S, Qualman S: Protocol for the examination of specimens from pediatric and adult patients with extragonadal germ cell tumors. Arch Pathol Lab Med 2011;135:630-639.
21.
Brodsky J, Kanwar V, Stafford L, Rahbar R, Frazier L: Germ cell tumors/teratoma; in Rahbar R, Rodriguez-Galindo C, Meara J, Smith E, Perez-Atayde (eds): Pediatric Head and Neck Tumors: A-Z Guide to Presentation and Multimodality Management, vol 1. New York, Springer Science+Business Media, 2014, p 155.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.